|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.74 USD | +1.47% |
|
-2.02% | +12.61% |
| 02-11 | Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016. | CI |
| 02-09 | AstraZeneca's Evinova Enters Clinical Development AI Partnership Deal | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 15.11x | 6.31x | -0.08x | 3.29x | 10.23x | 10.8x | 4.06% | 124B | ||
| 31.13x | 19.01x | 0.68x | 11.79x | 23.7x | 24.84x | 0.63% | 929B | ||
| 22.11x | 7.49x | 0.25x | 6.52x | 18.12x | 19.88x | 2.12% | 587B | ||
| 64.64x | 22174.33x | 1.3x | 7.64x | 18.92x | 19.48x | 2.82% | 409B | ||
| 18.87x | 6.65x | 1x | 4.7x | 11.65x | 13.06x | 2.79% | 374B | ||
| 32.49x | 7.16x | 0.79x | 5.82x | 17.36x | 18.14x | 1.58% | 320B | ||
| 21.47x | 6.58x | 4.14x | 6x | 14.69x | 15.66x | 2.7% | 311B | ||
| 15.68x | 5.47x | 1.05x | 5.03x | 10.97x | 12.18x | 2.66% | 301B | ||
| 14.81x | 6.37x | -1.66x | 5.11x | 10.76x | 12.51x | 3.49% | 219B | ||
| 28.69x | 21.97x | 0.41x | 6.7x | 11.46x | 15.38x | 2.59% | 199B | ||
| 22.73x | 8.54x | 0.01x | 7.03x | 12.85x | 15.52x | 2.14% | 192B | ||
| 13.45x | 1.73x | 0.3x | 3.24x | 8.02x | 9.45x | 6.2% | 157B | ||
| 31.72x | 6.57x | -0.04x | 9.6x | 20.58x | 21.5x | -.--% | 125B | ||
| 15.59x | 6.04x | 0.13x | 3.11x | 8.99x | 10.47x | 2.99% | 118B | ||
| 11.57x | 1.21x | 0.25x | 2.44x | 7.96x | 8.77x | 5.3% | 111B | ||
| 35.68x | 7.72x | 3.4x | 11.53x | 22.66x | 24.16x | 2.73% | 99.9B | ||
| 51.65x | 1.28x | 0.88x | 2.86x | 10.81x | 30.41x | 3.56% | 58.01B | ||
| 44.26x | 6.32x | 1.4x | 10.57x | 35.36x | 36.82x | 0.45% | 55.97B | ||
| 142.03x | 1.38x | -1.26x | 1.69x | 8.1x | 13.97x | 0.24% | 53.62B | ||
| 23.23x | 2.21x | 1.91x | 3.97x | 15.72x | 17.58x | 1.73% | 49.67B | ||
| Average | 32.85x | 1,115.22x | 0.74x | 5.93x | 14.94x | 17.53x | 2.54% | 239.67B | |
| Weighted average by Cap. | 29.08x | 1,901.53x | 0.80x | 7.02x | 16.36x | 18.00x | 2.27% |
- Stock Market
- Equities
- BMY Stock
- Sector Bristol-Myers Squibb Company
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















